To test this, we treated BC cells (MDA-MB-231 and MDA-MB-468) with human IL-6 neutralizing antibody (rabbit polyclonal) prior to resistin stimulation and followed changes in STAT3 phosphorylation and expression by immunoblot assay. This evidence concerns the gene RETN and breast cancer.